The present study characterized in vitro metabolites of 20(R)-25-methoxyl-dammarane-3b, 12b, 20-triol (20(R)-25-OCH3-PPD) in mouse, rat, dog, monkey and human liver microsomes. 20(R)-25-OCH3-PPD was incubated with liver microsomes in the presence of NADPH. The reaction mixtures and the metabolites were identified on the basis of their mass profiles using LCQ/ TOF and were quantified using triple quadrupole instrument by multiple reaction monitoring. A total of 7 metabolites (M1-M7) of the phase I metabolites were detected in all species. 25(R)-OCH3-PPD was metabolized by hydroxylation, dehydrogenation, and O-demethylation. Enzyme kinetic of 20(R)-25-OCH3-PPD metabolism was evaluated in rat and human hepatic microsomes. Incubations studies with selective chemical inhibitors demonstrated that the metabolism of 20(R)-25- OCH3-PPD was primarily mediated by CYP3A4. We conclude that 20(R)-25-OCH3-PPD was metabolized extensively in mammalian species of mouse, rat, dog, monkey, and human. CYP3A4-catalyzed oxygenation metabolism played an important role in the disposition of 25(R)-OCH3-PPD, especially at the C-20 hydroxyl group. © 2014 Zhang et al.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Zhang, X., Zhang, J., Li, W., Liu, L., Sun, B., Guo, Z., … Zhao, Y. (2014). In vitro metabolism of 20(R)-25-methoxyl-dammarane-3, 12, 20-triol from panax notoginseng in human, monkey, dog, rat, and mouse liver microsomes. PLoS ONE, 9(4). https://doi.org/10.1371/journal.pone.0094962